DMT210 Topical Gel
DMT210-002
Phase 2 small_molecule completed
Quick answer
DMT210 Topical Gel for Atopic Dermatitis is a Phase 2 program (small_molecule) at Dermata Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Dermata Therapeutics
- Indication
- Atopic Dermatitis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed